Class IIOngoingD-0394-2026
Drug recall · March 11, 2026
Tirzepatide Inj recall
Why: Lack of Assurance of Sterility
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Tirzepatide Inj, 10mg, Sterile Multi-Dose Vial, Rx only, Nomida, 25055 W Valley Pkwy, Suite 106, Olathe, KS 66061, NDC 84223-002-03.
- Lots / codes
Lot 240709, exp 7/31/2026
- Quantity
- 23 vials
- Company
- New Life Pharma LLC, Northvale, NJ
- Distribution
- OH
- Initiated
- February 26, 2026 · Voluntary: Firm initiated
- Classified
- March 17, 2026
- Reported
- March 11, 2026
- How notified
- Letter
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.